Universal Health Realty Income Trust
UHTNYSECIK 798783Real estateFiscal year ends Dec 31
Reports and events: 217 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2716:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-434277 |
| 2026-08-0716:15 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-340281 |
| 2026-07-2716:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-318144 |
| 2026-06-1116:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-26-267569 |
| 2026-05-0716:17 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-211984 |
| 2026-04-2806:30 ET | DEF 14A | Proxy statementPeriod 2026-06-10 | 0001193125-26-183412 |
| 2026-04-2716:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-182162 |
| 2026-04-2408:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-175196 |
| 2026-02-2516:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-071714 |
| 2026-02-2516:16 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-071594 |
| 2025-11-0716:15 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-272382 |
| 2025-10-2716:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-251645 |
| 2025-08-0816:15 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001193125-25-177000 |
| 2025-07-2816:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-099202 |
| 2025-06-1216:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000950170-25-085399 |
| 2025-05-0816:16 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-067009 |
| 2025-04-2816:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-059340 |
| 2025-04-2506:30 ET | DEF 14A | Proxy statementPeriod 2025-06-11 | 0000950170-25-058306 |
| 2025-02-2616:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-027870 |
| 2025-02-2616:47 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-027861 |
| 2024-11-0816:20 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-124121 |
| 2024-10-2416:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-117069 |
| 2024-10-0211:13 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-230879 |
| 2024-08-0816:20 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-094044 |
| 2024-07-2416:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-086074 |
| 2024-06-0616:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000950170-24-069899 |
| 2024-05-0816:20 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-055718 |
| 2024-04-2416:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-047606 |
| 2024-04-2306:30 ET | DEF 14A | Proxy statementPeriod 2024-06-05 | 0001193125-24-105818 |
| 2024-02-2716:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-021213 |
| 2024-02-2716:20 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-021191 |
| 2023-11-0816:20 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-061157 |
| 2023-10-2516:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-055221 |
| 2023-08-0816:24 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-039868 |
| 2023-07-2516:42 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-034455 |
| 2023-06-0816:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000950170-23-027006 |
| 2023-05-1616:28 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950170-23-022481 |
| 2023-05-0909:11 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-019195 |
| 2023-04-2516:43 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-014481 |
| 2023-04-2506:16 ET | DEF 14A | Proxy statement | 0001193125-23-113887 |
| 2023-02-2716:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-004677 |
| 2023-02-2716:17 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-004655 |
| 2022-12-0116:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001564590-22-038816 |
| 2022-11-0816:06 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001564590-22-037037 |
| 2022-10-2516:52 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-22-035131 |
| 2022-08-0816:16 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001564590-22-028444 |
| 2022-07-2516:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-22-026321 |
| 2022-06-0916:15 ET | 8-K | 5.07 Shareholder vote results | 0001564590-22-022872 |
| 2022-05-0616:00 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001564590-22-018568 |
| 2022-04-2606:17 ET | DEF 14A | Proxy statementPeriod 2022-06-08 | 0001193125-22-118718 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:26 ET. Listed shows no prices and gives no investment advice.